AbbVie claimed FDA approval for its JAK inhibitor Rinvoq (upadacitinib) for rheumatoid arthritis on Friday, setting its price just a little below that of its antibody blockbuster Humira.

You'll need passive income to live well in retirement, especially with Social Security's uncertain future. The Office of ...

There are a lot of games for iPhone, and while the big names are usually fun enough to play, if you’ve ever tried out free games such as Crowd City, or Helix Jump on your iPhone you must have noticed ...

目前，强生正在加速拓展古塞奇尤单抗的适应症范围，2025 年预计将有 6 个新适应症获批上市，包括溃疡性结肠炎（皮下诱导）、克罗恩病（皮下诱导）、儿童银屑病、克罗恩病、幼年型银屑病关节炎、溃疡性结肠炎，意味着未来有望进入加速放量期。

Solana has removed its "America is Back—Time to Accelerate" ad, following intense criticism from the crypto community on X, with labels such as "offensive," "cringe," and "divisive." The now-deleted ...

HUL uses ASMR to promote its foray into herbal tea category with Pukka ...

The information on this website is for educational purposes only, and investing carries risks. Always do your research before investing, and be prepared for potential losses. 18+ and Gambling: Online ...

Analysts have suggested that with a large-scale study backing up the risks, Xeljanz now runs the risk of falling behind its rivals, including AbbVie’s much-touted Rinvoq (upadacitinib).

Product-related advancements also played a crucial role, such as the FDA's approval of RINVOQ for ankylosing spondylitis in April 2022. Despite challenges like declining net income and ongoing ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Solana removes its controversial ad after receiving community backlash. The ad was criticized for featuring gender identity themes. Solana VP states that not many team members were involved in the ad ...